Jeffrey P. George's most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 40,258 Restricted Stock Units done . Disclosure was reported to the exchange on May 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 309,795 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 34,819 | 34,819 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 269,537 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 40,258 | 40,258 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 193,084 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 76,453 | 76,453 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2022 | 80,128 | 80,128 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 112,956 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 46,218 | 77,550 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 46,218 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 35,406 | 35,406 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 7,522 | 31,332 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc | Jeffrey P. George | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 7,522 | 0 | - | - | Restricted Stock Units |